K190882

Substantially Equivalent

XenoSure Biologic Patch

Applicant: Lemaitre Vascular
Product code: PSQ
Advisory panel: Cardiovascular
Date received: 2019-04-04
Decision date: 2020-02-13
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Burlington, MA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.